Safety and Efficacy of Empagliflozin in Hemodialysis
Condition: End Stage Renal Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Sponsors: NYU Langone Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2023 Category: Research Source Type: clinical trials
Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction
Condition: Heart Failure With Reduced Ejection Fraction Intervention: Drug: Empagliflozin 10 MG Sponsor: Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2023 Category: Research Source Type: clinical trials